Evaluation of Sleep Pattern and Mood Profile in Hypertensive Patients

March 6, 2020 updated by: Giselle Soares Passos, Universidade Federal de Goias

Sleep, Mood and Physical Activity Level in Patients With Hypertension

Introduction: Sleep disturbances may contribute to impairments in mood, occupational and intellectual performance, and social relationships, as well as being associated with cardiovascular diseases, such as arterial hypertension. Sedentary lifestyle has often been associated with poor sleep quality and hypertension; regular exercise has been studied as a coadjuvant therapy for hypertension and/or for some sleep disorders. Objective: To compare sleep pattern of active and inactive patients with arterial hypertension, as well as to evaluate complaints of depression and anxiety, and the mood profile. Material and Methods: Polysomnography, Pittsburgh Sleep Quality Index and Epworth Sleepiness Scale will be used to assess the sleep pattern. Depression will be assessed by the Beck Depression Inventory (BDI), Beck Anxiety Inventory (BAI) anxiety, and mood pattern by the State of Mood Profile (POMS). The level of physical activity will be recorded by the number of steps taken (pedometer). Participating in the study will be 60 hypertension patients (ACTIVE, n=30; INACTIVE, n=30). Hypothesis: Active hypertensive patients better quality of sleep, better mood profile, and fewer complaints of depression and anxiety when compared to physically inactive hypertensive patients.

Study Overview

Status

Completed

Conditions

Study Type

Observational

Enrollment (Actual)

60

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • GO
      • Rio Verde, GO, Brazil, 75906-805
        • Anna Paula Ribeiro Campos

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

30 years to 60 years (ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Male

Sampling Method

Probability Sample

Study Population

Participating in the study will be 60 males hypertension patients (ACTIVE, n=30; INACTIVE, n=30) with age between 30 and 60 years old. All participants should be under antihypertensive drug treatment.

Description

Inclusion Criteria:

  • Diagnosis of systemic arterial hypertension, according to the VII Brazilian Guidelines for Hypertension;
  • male;
  • BMI <30;
  • Age between 30 and 60 years;
  • Minimum level of education: elementary school

Exclusion Criteria:

  • Present pathologies in the musculoskeletal and neurological systems, or incapacitating complaints in these systems;
  • Diagnosis of psychiatric disorder;
  • Being under medical treatment for insomnia or other psychiatric treatment.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
ACTIVE
Participating in this group will be 30 active hypertension patients who exercise at least 3 times a week for at least 30 minutes
No intervential
INACTIVE
Participating in this group will be 30 inactive hypertension patients who do not exercise.
No intervential

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Sleep
Time Frame: 3 months
Polysomnography, Pittsburgh Sleep Quality Index
3 months
Exercise
Time Frame: 3 months
Normal Physical Activity Level, Pedometer
3 months
Mood
Time Frame: 3 months
Profile of Mood States
3 months
Anxiety
Time Frame: 3 months
Beck Anxiety Inventory
3 months
Depression
Time Frame: 3 months
Beck Depression Inventory
3 months
Daytime drowsiness
Time Frame: 3 months
Epworth Sleepiness Scale
3 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Giselle Passos, PHD, World Health Organization

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

September 25, 2017

Primary Completion (ACTUAL)

December 30, 2018

Study Completion (ACTUAL)

January 6, 2020

Study Registration Dates

First Submitted

May 20, 2017

First Submitted That Met QC Criteria

May 20, 2017

First Posted (ACTUAL)

May 23, 2017

Study Record Updates

Last Update Posted (ACTUAL)

March 10, 2020

Last Update Submitted That Met QC Criteria

March 6, 2020

Last Verified

March 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • 1.986.587

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Sleep

Clinical Trials on No intervantion. It´s a Cross-Sectional Study

3
Subscribe